NCT01921322View on ClinicalTrials.gov

Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Type 2 Diabetes
Interventions
DEVICE

Pump

722 Paradigm Real-Time System

OTHER

CGMS Gold

Device used to collect retrospective sensor data, blinded to the subjects, to compare to the treatment arm

Trial Locations (2)

Unknown

The Second Hospital of Jilin University, Changchun

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT01921322 - Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy | Biotech Hunter | Biotech Hunter